During the past decade, Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Pfizer" with 6 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored, "Cortendo AB" with 1 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" are "Ulcerative Colitis" (6 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" in a lesser frequency.

Most popular intervention types in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" are "Drug" (19 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Etrasimod" (3 trials), "Capecitabine" (2 trials), "Chemotherapy" (2 trials) and "PF-06651600" (2 trials). Other intervention names were less common.

The vast majority of trials in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".